1. Home
  2. REED vs CNSP Comparison

REED vs CNSP Comparison

Compare REED & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Reed's Inc.

REED

Reed's Inc.

N/A

Current Price

$0.64

Market Cap

9.1M

Sector

N/A

ML Signal

N/A

Logo CNS Pharmaceuticals Inc.

CNSP

CNS Pharmaceuticals Inc.

N/A

Current Price

$5.35

Market Cap

8.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
REED
CNSP
Founded
1987
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.1M
8.5M
IPO Year
2009
2019

Fundamental Metrics

Financial Performance
Metric
REED
CNSP
Price
$0.64
$5.35
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 142.8K
2.5K
Earning Date
08-11-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 8.03
EPS
★ N/A
N/A
Revenue
★ $34,065,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$27.29
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.56
$1.90
52 Week High
$5.97
$10.54

Technical Indicators

Market Signals
Indicator
REED
CNSP
Relative Strength Index (RSI) 38.60 49.80
Support Level $0.63 $5.15
Resistance Level $0.94 $5.53
Average True Range (ATR) 0.06 0.17
MACD 0.01 0.03
Stochastic Oscillator 45.25 74.69

Price Performance

Historical Comparison
REED
CNSP

About REED Reed's Inc.

Reed's Inc is a branded beverage company offering a portfolio of natural, premium, and functional beverages under the Reed's and Virgil's brands. The company's portfolio of handcrafted, all-natural beverages is sold in outlets nationwide, including the natural and specialty food channel, grocery stores, mass merchants, drug stores, convenience stores, club stores, and on-premise locations, including bars and restaurants. The company operates in a single reportable segment, which consists of manufacturing carbonated beverages under Reed's and Virgil's brand names.

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.

Share on Social Networks: